ARTICLE | Distillery Therapeutics
Renal
January 25, 2017 5:31 PM UTC
Monkey studies suggest inhibiting MAC-1 could help treat chronic kidney disease (CKD) associated with acute kidney injury (AKI). In a monkey model of AKI-induced CKD, a mAb inhibiting the CR3 portion ...
BCIQ Company Profiles
BCIQ Target Profiles